Screener
Cytokinetics CYTK Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Cytokinetics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Cytokinetics’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:30 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338217
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Cost of goods sold | 2,731 | — | 2,891 | — |
| Collaboration cost of revenues | 2,861 | 2,416 | 5,253 | 3,995 |
| Total operating expenses | 207,796 | 178,275 | 410,769 | 335,485 |
| Operating loss | (179,172) | (111,506) | (362,790) | (267,137) |
| Interest and other expense, net | (14,654) | (11,084) | (29,173) | (19,952) |
| Non-cash interest expense on liabilities related to revenue participation right purchase agreements | (20,177) | (13,181) | (38,993) | (27,259) |
| Interest and other income, net | 13,941 | 13,001 | 24,963 | 26,702 |
| Change in fair value of derivative liabilities | (1,100) | 3,000 | 400 | 2,600 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Cytokinetics's operating income?
- Cytokinetics (CYTK) reported operating income of -$179.17M in Q2 2026.
- How has Cytokinetics's operating income changed year-over-year?
- Cytokinetics's operating income decreased by 60.7% year-over-year, from -$111.51M to -$179.17M.
- What is the long-term trend for Cytokinetics's operating income?
- Over 4 years (2021 to 2025), Cytokinetics's operating income has grown at a 34.6% compound annual growth rate (CAGR), from -$186.31M to -$612.26M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Cytokinetics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude